Found 0 matching trials
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
N/AThis Expanded Access Program (EAP) consists of a Prerandomization Phase and...
Status
Approved For Marketing
Location
Multiple Locations
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NASubjects: patients with postoperative local recurrent or metastatic differe...
Location
Nanjing First Hospital
Salivary dysfuncTion After Radioiodine Treatment
N/AAim/Introduction:
The treatment of differentiated thyroid cancer includes ...
Location
Pitié-Salpêtrière hospital
Effect of Radioiodine Therapy on Ovarian Reserve in Female Patients With Differentiated Thyroid Cancer
NAThyroid carcinoma is the most common endocrine malignancy. Surgery is the s...
Location
Multiple Locations
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
NAIn this study, we comprehensively evaluated the clinical utility of Trop2 P...
Location
The First Affiliated Hospital of Xiamen University
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
PHASE2Study rationale
High risk patients with differentiated thyroid cancer (DTC...
Location
National Institutes of Health Clinical Center
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
NAThe goal of this study is to learn if a decision aid (DA) website helps peo...
Location
Lombardi Comprehensive Cancer Center
The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma
N/AClinincal data and pathological specimens from patients who had undergone a...
Status
Active Not Recruiting
Location
Jiangxi Cancer Hospital
Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality
N/ABone radioiodine (RAI) uptake without structural abnormality in thyroid can...
Location
Multiple Locations
Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379
PHASE1This is a patient pilot study testing the hypothesis that vemurafenib with ...
Location
Memorial Sloan-Kettering Cancer Center